Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02513121 · ClinicalTrials.gov registry record · NA
Dietary Treatment Study of Pediatric NAFLD
A NA study of Nonalcoholic Fatty Liver Disease, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 2
- Study locations
NCT02513121 is a NA study of Nonalcoholic Fatty Liver Disease that has completed, run by University of California, San Diego. The registered enrollment target is 40 participants, below the 111-participant average among 9 other Nonalcoholic Fatty Liver Disease trials with a reported enrollment target (64% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT02513121, a NA study of Nonalcoholic Fatty Liver Disease, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is an investigator initiated study being conducted in equal numbers at two sites, University of California, San Diego (UC San Diego) and Emory University (EU). The purpose of this study is to understand the potential of a low sugar diet for the treatment of nonalcoholic fatty liver disease (NAFLD) in children. Forty boys with NAFLD will be randomly assigned to either an intervention group or a habitual diet control group. The intervention will be a low sugar diet for a period of 8 weeks. The effect of this dietary change will be assessed using advanced magnetic resonance imaging (MRI) testing to measure liver fat.
Conditions Studied
Interventions
- OTHER Dietary modification
Study Locations (2)
California
- University of California, San Diego - San Diego
Georgia
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-07 |
| Est. Completion | 2017-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02513121
The ClinicalTrials.gov registry entry for NCT02513121 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 111-participant average among 9 other Nonalcoholic Fatty Liver Disease trials with a reported enrollment target (64% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nonalcoholic Fatty Liver Disease appearing as the primary indexed condition, and to 1 intervention - of which Dietary modification is the first listed.
NCT02513121 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Georgia.
Frequently Asked Questions
What is clinical trial NCT02513121 about?
NCT02513121 is a clinical study titled "Dietary Treatment Study of Pediatric NAFLD". This is an investigator initiated study being conducted in equal numbers at two sites, University of California, San Diego (UC San Diego) and Emory University (EU). The purpose of this study is to understand the potential of a low sugar diet for the treatment of nonalcoholic fatty liver disease (NAF...
What is the current status of trial NCT02513121?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-07. Estimated completion is 2017-08-31.
What conditions does trial NCT02513121 study?
This clinical trial studies the following conditions: Nonalcoholic Fatty Liver Disease.
What interventions are being tested in trial NCT02513121?
The interventions under investigation include: Dietary modification (OTHER).
Who is sponsoring clinical trial NCT02513121?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02513121 being conducted?
This trial has 2 study locations across California, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nonalcoholic Fatty Liver Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effectiveness of Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
RECRUITING
-
Patient and Physician Perspectives on Non-Alcoholic Fatty Liver Disease
ACTIVE NOT RECRUITING
-
Phase 2b Study of GSK4532990 in Adults With NASH
ACTIVE NOT RECRUITING · Phase 2
-
Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)
COMPLETED · Phase 2
-
Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes
COMPLETED · Phase 3
-
Autonomic Dysfunction in Non-Alcoholic Fatty Liver Disease
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.